URGENT: This Altcoin Opportunity Won’t Wait – Act Now

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

Wilhelmus Cm Groenhuysen net worth and biography

Wilhelmus Groenhuysen Biography and Net Worth

COO of NovoCure

Wilco Groenhuysen has served as Novocure’s Chief Operating Officer since September 2020. He is responsible for the general and administrative management of the company, the strategic and operational leadership of Novocure’s supply chain, warehousing and distribution, quality assurance and information technology operations. Mr. Groenhuysen is tasked to ensure organizational readiness in anticipation of the completion of four phase 3 clinical trials over the next few years.

From January 2012 to August 2020, Mr. Groenhuysen served as the Company’s Chief Financial Officer. He has served on the Board of Optinose Inc., a commercial-stage specialty pharmaceuticals company, since October 2017. From 2007 to 2011, Mr. Groenhuysen worked for Cephalon, Inc., a U.S. biopharmaceutical company, last serving as executive vice president and chief financial officer, where he had responsibility for worldwide finance, commercial operations and risk management. From 1987 to 2007, Mr. Groenhuysen worked for Philips Group in various assignments in Europe, Asia and the United States, the latest of which started in 2002 when he was promoted to chief financial officer and senior vice president of Philips Electronics North America Corporation. Mr. Groenhuysen holds a Master’s Degree in Business Economics from VU University Amsterdam and graduated as a Registered Public Controller at VU University Amsterdam.

What is Wilhelmus Cm Groenhuysen's net worth?: The estimated net worth of Wilhelmus Cm Groenhuysen is at least $7.74 million as of March 4th, 2024. Mr. Groenhuysen owns 251,235 shares of NovoCure stock worth more than $7,738,038 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Groenhuysen may own. Additionally, Mr. Groenhuysen receives an annual salary of $965,560.00 as COO at NovoCure. Learn More about Wilhelmus Cm Groenhuysen's net worth.
How old is Wilhelmus Cm Groenhuysen?: Mr. Groenhuysen is currently 66 years old. There are 7 older executives and no younger executives at NovoCure. The oldest executive at NovoCure is Prof. Yoram Palti M.D., Ph.D., Founder & CTO, who is 86 years old. Learn More on Wilhelmus Cm Groenhuysen's age.
What is Wilhelmus Cm Groenhuysen's salary?: As the COO of NovoCure Limited, Mr. Groenhuysen earns $965,560.00 per year. There are 2 executives that earn more than Mr. Groenhuysen. The highest earning executive at NovoCure is Mr. Asaf Danziger, CEO & Director, who commands a salary of $1,520,000.00 per year. Learn More on Wilhelmus Cm Groenhuysen's salary.
How do I contact Wilhelmus Cm Groenhuysen?: The corporate mailing address for Mr. Groenhuysen and other NovoCure executives is NO. 4 THE FORUM GRENVILLE STREET, ST. HELIER Y9, JE2 4UF. NovoCure can also be reached via phone at 441534756700 and via email at [email protected]. Learn More on Wilhelmus Cm Groenhuysen's contact information.
Has Wilhelmus Cm Groenhuysen been buying or selling shares of NovoCure?: Wilhelmus Cm Groenhuysen has not been actively trading shares of NovoCure during the last quarter. Most recently, Wilhelmus Cm Groenhuysen sold 1,217 shares of the business's stock in a transaction on Monday, March 4th. The shares were sold at an average price of $16.01, for a transaction totalling $19,484.17. Following the completion of the sale, the chief operating officer now directly owns 251,235 shares of the company's stock, valued at $4,022,272.35. Learn More on Wilhelmus Cm Groenhuysen's trading history.
Who are NovoCure's active insiders?: NovoCure's insider roster includes Michael Ambrogi (COO), Ely Benaim (Insider), Ashley Cordova (CFO), Asaf Danziger (CEO), William Doyle (Executive Chairman), Wilhelmus Groenhuysen (COO), Jeryl Hilleman (Director), Frank Leonard (Insider), Gabriel Leung (Director), Todd Longsworth (General Counsel), Martin Madden (Director), Pritesh Shah (Insider), and Uri Weinberg (Insider). Learn More on NovoCure's active insiders.
Are insiders buying or selling shares of NovoCure?: During the last twelve months, insiders at the medical equipment provider sold shares 10 times. They sold a total of 11,141 shares worth more than $188,910.17. The most recent insider tranaction occured on November, 1st when EVP Frank X Leonard sold 598 shares worth more than $9,532.12. Insiders at NovoCure own 6.3% of the company. Learn More about insider trades at NovoCure.
Information on this page was last updated on 11/1/2024.

Wilhelmus Cm Groenhuysen Insider Trading History at NovoCure

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/4/2024	Sell	1,217	$16.01	$19,484.17	251,235
3/1/2024	Sell	2,107	$16.03	$33,775.21	252,452
9/1/2023	Sell	294	$21.82	$6,415.08	209,825
3/1/2023	Sell	2,164	$76.36	$165,243.04	184,615
3/8/2022	Sell	2,923	$70.10	$204,902.30
3/3/2022	Sell	1,301	$74.50	$96,924.50
9/2/2021	Sell	181	$138.23	$25,019.63
2/28/2021	Sell	3,670	$72.22	$265,047.40	150,014
9/17/2020	Sell	12,500	$108.60	$1,357,500.00	144,540
9/15/2020	Sell	50,868	$103.27	$5,253,138.36	155,107
2/25/2020	Sell	18,908	$81.16	$1,534,573.28	130,676
1/22/2020	Sell	2,915	$98.14	$286,078.10	88,858
11/18/2019	Sell	25,832	$90.68	$2,342,445.76
11/14/2019	Sell	27,576	$81.87	$2,257,647.12	97,179
11/11/2019	Sell	8,600	$80.13	$689,118.00	89,079
9/24/2019	Sell	7,992	$80.63	$644,394.96	89,179
9/16/2019	Sell	25,000	$78.93	$1,973,250.00	112,179
9/12/2019	Sell	25,000	$79.57	$1,989,250.00	112,179
9/9/2019	Sell	25,000	$80.83	$2,020,750.00	112,179
3/5/2019	Sell	90,000	$53.94	$4,854,600.00	85,030
2/28/2019	Sell	3,288	$53.68	$176,499.84	69,552
1/25/2019	Sell	35,000	$49.20	$1,722,000.00	72,149
1/23/2019	Sell	35,000	$47.35	$1,657,250.00	72,149
1/18/2019	Sell	30,000	$45.90	$1,377,000.00	67,149
1/15/2019	Sell	30,000	$44.20	$1,326,000.00	67,149
1/11/2019	Sell	30,000	$42.35	$1,270,500.00	37,149
8/27/2018	Sell	35,547	$40.01	$1,422,235.47	47,397
8/24/2018	Sell	25,574	$40.00	$1,022,960.00	47,397
8/22/2018	Sell	31,179	$37.67	$1,174,512.93	72,671
8/14/2018	Sell	4,368	$37.62	$164,324.16	108,118
8/1/2018	Sell	1,241	$35.01	$43,447.41	115,644
7/27/2018	Sell	62,727	$35.08	$2,200,463.16	175,602
5/14/2018	Sell	30,470	$30.04	$915,318.80	201,898
5/11/2018	Sell	9,393	$30.01	$281,883.93	201,898
5/1/2018	Sell	30,470	$27.58	$840,362.60
2/23/2018	Sell	13,351	$19.83	$264,750.33	252,412
1/9/2018	Sell	31,132	$21.02	$654,394.64	240,210
1/4/2018	Sell	28,868	$21.03	$607,094.04	268,568

Wilhelmus Cm Groenhuysen Buying and Selling Activity at NovoCure

NovoCure Company Overview

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Today's Range

Now: $30.80

$30.33

$31.52

50 Day Range

MA: $21.12

$15.18

$33.41

2 Week Range

Now: $30.80

$11.70

$34.13

Volume

1,820,699 shs

Average Volume

1,336,846 shs

Market Capitalization

$3.33 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.75

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

>> Register for the Workshop Now

Wilhelmus Groenhuysen Biography and Net Worth

What is Wilhelmus Cm Groenhuysen's net worth?

How old is Wilhelmus Cm Groenhuysen?

What is Wilhelmus Cm Groenhuysen's salary?

How do I contact Wilhelmus Cm Groenhuysen?

Has Wilhelmus Cm Groenhuysen been buying or selling shares of NovoCure?

Who are NovoCure's active insiders?

Are insiders buying or selling shares of NovoCure?